• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); High Test Results (2457)
Patient Problem Pulmonary Embolism (1498)
Event Date 02/25/2022
Event Type  Injury  
Manufacturer Narrative
The meter and test strips were requested for investigation.The product has not been received at this time.If the product is returned in the future, a follow up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling, "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods.".
 
Event Description
The initial reporter alleged a questionable inr result from coaguchek vantus meter serial number (b)(4).The patient is in the hospital for a saddle pulmonary embolism (pe); a large blood clot in the main pulmonary artery.On (b)(6) 2022 the meter result at 11:25 a.M.Was reportedly 2.2 inr.No changes were reportedly made to the patient¿s warfarin dose based on this result.On (b)(6) 2022 the patient reportedly experienced shortness of breath and passed out; the patient was taken to the hospital via ambulance.On (b)(6) 2022 the result from an unknown laboratory method at 11:47 a.M.Was reportedly 1.57 inr.The patient reportedly had a cat scan that diagnosed the saddle pe.The patient reportedly was treated with a heparin drip.The patient¿s therapeutic range prior to the event was allegedly 2 ¿ 3 inr.Following the event, the patient¿s therapeutic range was allegedly changed to 2.5 ¿ 3.5 inr.The patient allegedly tests every 2 weeks.The patient is reportedly still in the hospital in stable condition.
 
Manufacturer Narrative
The device code and an evaluation code were updated.The customer did not return any product.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key13937675
MDR Text Key288095490
Report Number1823260-2022-00888
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K170960
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number04625374160
Device Lot NumberASKU
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/02/2022
Initial Date FDA Received03/29/2022
Supplement Dates Manufacturer Received05/02/2022
Supplement Dates FDA Received05/23/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
WARFARIN
Patient Outcome(s) Hospitalization;
Patient Age48 YR
Patient SexFemale
Patient Weight177 KG
-
-